Skip to content

Clinical trials

Observational Metabolic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Observational Country / region: United States Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20042
20057
20066
20075
20088
20097
20104
20117
20125
20132
20146
20161
20171
20182
20191
20202
20222
20232
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting11
Unknown status6
Terminated4
Active, not recruiting3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Longevity Metrics, Inc.3
Massachusetts General Hospital3
National Institute on Aging (NIA)3
University of California, Irvine3
Columbia University2
Emory University2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Pennington Biomedical Research Center2
Tufts Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome86
Obesity29
Diabetes Mellitus16
Cardiovascular Diseases14
Insulin Resistance12
Diabetes Mellitus, Type 29
Hypertension8
Glucose Intolerance6
Inflammation6
Cognitive Dysfunction5

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.